Evidence map›Paper›PMID 35886046›Full record

ArticleGenes2022

Wenli Zhao, Hitoe Mori, Yuki Tomiga, Kenichi Tanaka, Rasheda Perveen, Keiichiro Mine, Chika Inadomi, Wataru Yoshioka, Yoshihito Kubotsu, Hiroshi Isoda and 10 more

Open access · goldAbstract read
In one paragraph

Article in Genes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 3 institutions in 2 countries.

Wenli ZhaoDivision of Metabolism and Endocrinology, Faculty of Medicine, Saga University, Saga 849-8501, Japan.
Hitoe MoriDivision of Metabolism and Endocrinology, Faculty of Medicine, Saga University, Saga 849-8501, Japan.
Yuki TomigaDivision of Metabolism and Endocrinology, Faculty of Medicine, Saga University, Saga 849-8501, Japan.
Kenichi TanakaDivision of Metabolism and Endocrinology, Faculty of Medicine, Saga University, Saga 849-8501, Japan.
Rasheda PerveenDivision of Metabolism and Endocrinology, Faculty of Medicine, Saga University, Saga 849-8501, Japan.
Keiichiro MineDivision of Metabolism and Endocrinology, Faculty of Medicine, Saga University, Saga 849-8501, Japan.ORCID 0000-0001-9759-4148
Chika InadomiDivision of Metabolism and Endocrinology, Faculty of Medicine, Saga University, Saga 849-8501, Japan.
Wataru YoshiokaDivision of Metabolism and Endocrinology, Faculty of Medicine, Saga University, Saga 849-8501, Japan.
Yoshihito KubotsuDivision of Metabolism and Endocrinology, Faculty of Medicine, Saga University, Saga 849-8501, Japan.
Hiroshi IsodaLiver Center, Saga University Hospital Faculty of Medicine, Saga University, Saga 849-8501, Japan.
Takuya KuwashiroDivision of Metabolism and Endocrinology, Faculty of Medicine, Saga University, Saga 849-8501, Japan.
Satoshi OedaLiver Center, Saga University Hospital Faculty of Medicine, Saga University, Saga 849-8501, Japan.
Takumi AkiyamaDivision of Metabolism and Endocrinology, Faculty of Medicine, Saga University, Saga 849-8501, Japan.
Ye ZhaoInnovative Institute of Chinese Medicine and Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250014, China.
Iwata OzakiDivision of Metabolism and Endocrinology, Faculty of Medicine, Saga University, Saga 849-8501, Japan.ORCID 0000-0001-8542-1434
Seiho NagafuchiDivision of Metabolism and Endocrinology, Faculty of Medicine, Saga University, Saga 849-8501, Japan.ORCID 0000-0002-8790-8358
Atsushi KawaguchiEducation and Research Center for Community Medicine, Faculty of Medicine, Saga University, Saga 849-8501, Japan.
Shinichi AishimaDepartment of Pathology and Microbiology, Faculty of Medicine, Saga University, Saga 849-8501, Japan.
Keizo AnzaiDivision of Metabolism and Endocrinology, Faculty of Medicine, Saga University, Saga 849-8501, Japan.
Hirokazu TakahashiDivision of Metabolism and Endocrinology, Faculty of Medicine, Saga University, Saga 849-8501, Japan.ORCID 0000-0003-1900-4389
Saga University · JPKyushu University · JPShandong University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is an association between nonalcoholic fatty liver disease (NAFLD) and atherosclerosis, but the genetic risk of atherosclerosis in NAFLD remains unclear. Here, a single-nucleotide polymorphism (SNP) of the heat shock 70 kDa protein 8 (

Indexed as

AtherosclerosisCarotid Artery DiseasesNon-alcoholic Fatty Liver DiseaseCarotid ArteriesCarotid Intima-Media ThicknessHSC70 Heat-Shock ProteinsHumansMalePolymorphism, Single NucleotideHSC70 Heat-Shock ProteinsHSPA8 protein, humancardiovascular diseasecarotid artery ultrasoundliver biopsyprecision medicine

Identifiers

PMID35886046
PMCPMC9323248
OpenAlexW4285732559

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.